These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 15681835)
1. Accumulation of filamentous tau in the cerebral cortex of human tau R406W transgenic mice. Ikeda M; Shoji M; Kawarai T; Kawarabayashi T; Matsubara E; Murakami T; Sasaki A; Tomidokoro Y; Ikarashi Y; Kuribara H; Ishiguro K; Hasegawa M; Yen SH; Chishti MA; Harigaya Y; Abe K; Okamoto K; St George-Hyslop P; Westaway D Am J Pathol; 2005 Feb; 166(2):521-31. PubMed ID: 15681835 [TBL] [Abstract][Full Text] [Related]
2. Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert. Engel T; Goñi-Oliver P; Lucas JJ; Avila J; Hernández F J Neurochem; 2006 Dec; 99(6):1445-55. PubMed ID: 17059563 [TBL] [Abstract][Full Text] [Related]
3. Transgenic mouse model of tau pathology in astrocytes leading to nervous system degeneration. Forman MS; Lal D; Zhang B; Dabir DV; Swanson E; Lee VM; Trojanowski JQ J Neurosci; 2005 Apr; 25(14):3539-50. PubMed ID: 15814784 [TBL] [Abstract][Full Text] [Related]
4. Increased tau phosphorylation on mitogen-activated protein kinase consensus sites and cognitive decline in transgenic models for Alzheimer's disease and FTDP-17: evidence for distinct molecular processes underlying tau abnormalities. Lambourne SL; Sellers LA; Bush TG; Choudhury SK; Emson PC; Suh YH; Wilkinson LS Mol Cell Biol; 2005 Jan; 25(1):278-93. PubMed ID: 15601849 [TBL] [Abstract][Full Text] [Related]
5. Hyperphosphorylated tau aggregates in the cortex and hippocampus of transgenic mice with mutant human FTDP-17 Tau and lacking the PARK2 gene. Guerrero R; Navarro P; Gallego E; Garcia-Cabrero AM; Avila J; Sanchez MP Acta Neuropathol; 2009 Feb; 117(2):159-68. PubMed ID: 19057915 [TBL] [Abstract][Full Text] [Related]
6. Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies. Ferrer I; Gomez-Isla T; Puig B; Freixes M; Ribé E; Dalfó E; Avila J Curr Alzheimer Res; 2005 Jan; 2(1):3-18. PubMed ID: 15977985 [TBL] [Abstract][Full Text] [Related]
7. A mouse model to study tau pathology related with tau phosphorylation and assembly. Engel T; Lucas JJ; Hernández F; Avila J J Neurol Sci; 2007 Jun; 257(1-2):250-4. PubMed ID: 17362999 [TBL] [Abstract][Full Text] [Related]
8. Hyperexcitability and epileptic seizures in a model of frontotemporal dementia. García-Cabrero AM; Guerrero-López R; Giráldez BG; Llorens-Martín M; Avila J; Serratosa JM; Sánchez MP Neurobiol Dis; 2013 Oct; 58():200-8. PubMed ID: 23774255 [TBL] [Abstract][Full Text] [Related]
9. FTDP-17 mutations in tau transgenic mice provoke lysosomal abnormalities and Tau filaments in forebrain. Lim F; Hernández F; Lucas JJ; Gómez-Ramos P; Morán MA; Avila J Mol Cell Neurosci; 2001 Dec; 18(6):702-14. PubMed ID: 11749044 [TBL] [Abstract][Full Text] [Related]
10. Hippocampal neuronal subpopulations are differentially affected in double transgenic mice overexpressing frontotemporal dementia and parkinsonism linked to chromosome 17 tau and glycogen synthase kinase-3beta. Engel T; Goñi-Oliver P; Gomez-Ramos P; Morán MA; Lucas JJ; Avila J; Hernández F Neuroscience; 2008 Dec; 157(4):772-80. PubMed ID: 18951953 [TBL] [Abstract][Full Text] [Related]
11. Mutant (R406W) human tau is hyperphosphorylated and does not efficiently bind microtubules in a neuronal cortical cell model. Krishnamurthy PK; Johnson GV J Biol Chem; 2004 Feb; 279(9):7893-900. PubMed ID: 14660557 [TBL] [Abstract][Full Text] [Related]
12. A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease. Onishi T; Iwashita H; Uno Y; Kunitomo J; Saitoh M; Kimura E; Fujita H; Uchiyama N; Kori M; Takizawa M J Neurochem; 2011 Dec; 119(6):1330-40. PubMed ID: 21992552 [TBL] [Abstract][Full Text] [Related]
13. Suppression of Parkin enhances nigrostriatal and motor neuron lesion in mice over-expressing human-mutated tau protein. Menéndez J; Rodríguez-Navarro JA; Solano RM; Casarejos MJ; Rodal I; Guerrero R; Sánchez MP; Avila J; Mena MA; de Yébenes JG Hum Mol Genet; 2006 Jul; 15(13):2045-58. PubMed ID: 16698879 [TBL] [Abstract][Full Text] [Related]
14. Formation of filamentous tau aggregations in transgenic mice expressing V337M human tau. Tanemura K; Akagi T; Murayama M; Kikuchi N; Murayama O; Hashikawa T; Yoshiike Y; Park JM; Matsuda K; Nakao S; Sun X; Sato S; Yamaguchi H; Takashima A Neurobiol Dis; 2001 Dec; 8(6):1036-45. PubMed ID: 11741399 [TBL] [Abstract][Full Text] [Related]
15. Cortical neuronal and glial pathology in TgTauP301L transgenic mice: neuronal degeneration, memory disturbance, and phenotypic variation. Murakami T; Paitel E; Kawarabayashi T; Ikeda M; Chishti MA; Janus C; Matsubara E; Sasaki A; Kawarai T; Phinney AL; Harigaya Y; Horne P; Egashira N; Mishima K; Hanna A; Yang J; Iwasaki K; Takahashi M; Fujiwara M; Ishiguro K; Bergeron C; Carlson GA; Abe K; Westaway D; St George-Hyslop P; Shoji M Am J Pathol; 2006 Oct; 169(4):1365-75. PubMed ID: 17003492 [TBL] [Abstract][Full Text] [Related]
16. Increased tau phosphorylation in apolipoprotein E4 transgenic mice is associated with activation of extracellular signal-regulated kinase: modulation by zinc. Harris FM; Brecht WJ; Xu Q; Mahley RW; Huang Y J Biol Chem; 2004 Oct; 279(43):44795-801. PubMed ID: 15322121 [TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of mutant and wild-type tau deposited in the brain affected by the FTDP-17 R406W mutation. Miyasaka T; Morishima-Kawashima M; Ravid R; Heutink P; van Swieten JC; Nagashima K; Ihara Y Am J Pathol; 2001 Feb; 158(2):373-9. PubMed ID: 11159174 [TBL] [Abstract][Full Text] [Related]
18. Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy. Zhang B; Higuchi M; Yoshiyama Y; Ishihara T; Forman MS; Martinez D; Joyce S; Trojanowski JQ; Lee VM J Neurosci; 2004 May; 24(19):4657-67. PubMed ID: 15140937 [TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick's disease and fronto-temporal tauopathies. Rockenstein E; Ubhi K; Mante M; Florio J; Adame A; Winter S; Brandstaetter H; Meier D; Masliah E BMC Neurosci; 2015 Nov; 16():85. PubMed ID: 26611895 [TBL] [Abstract][Full Text] [Related]
20. A novel triple repeat mutant tau transgenic model that mimics aspects of pick's disease and fronto-temporal tauopathies. Rockenstein E; Overk CR; Ubhi K; Mante M; Patrick C; Adame A; Bisquert A; Trejo-Morales M; Spencer B; Masliah E PLoS One; 2015; 10(3):e0121570. PubMed ID: 25803611 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]